Stay updated with breaking news from Randomised Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Actemra/RoActemra reduced the risk of death in patients with severe COVID-19, as evidenced by a review of four phase III studiesThe European Commission is expected to make a final decision regarding approval
06.12.2021 - Actemra/RoActemra reduced the risk of death in patients with severe COVID-19, as evidenced by a review of four phase III studiesThe European Commission is expected to make a final decision regarding approval in the near future Basel, 06 December ... Seite 1
In a meta-analysis of six studies evaluating colchicine as a COVID-19 treatment, the anti-inflammatory drug for acute gout attacks did not appear to improve outcomes for patients.
The huge improvements in COVID-19 outcomes among critical care patients thanks to innovative trials and adaptive working practices could be lost if key lessons are not learned, warns UK clinician.
ICMR To Pair With Oxford For Clinical Trial Of COVID-19 Therapy Evaluation The trial, 'India-UK RECOVERY (Randomised Evaluation of COVID-19 therapy)', will be a multi-centre, adaptive platform trial on COVID patients, ICMR said on Friday. Outlook Web Desk 10 July 2021, Last Updated at 11:42 am PTI Outlook Web Desk 2021-07-10T11:11:35+05:30 ICMR To Pair With Oxford For Clinical Trial Of COVID-19 Therapy Evaluation outlookindia.com 2021-07-10T11:42:22+05:30 The Indian Council of Medical Research (ICMR) has proposed a collaborative endeavour of con...